Atlas Trials

Expanded Evaluation of the Survivorship Wellness Group Program in the Context of COVID-19 and Telehealth

Clinical trial NCT04630015 · COMPLETED

Trial details

NCT number
NCT04630015
Sponsor
University of California, San Francisco
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Start date
2020-08-31
Primary completion
2023-05-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.